Personalized Diagnostics

Personalized Diagnostics

By Joseph Anderson, MDNewsScienceMedicineHealth & FitnessTech NewsLife Sciences
Download on the App Store

Personalized Diagnostics episodes

  • Jeffery Taubenberger, MD, PhD, of the NIH, Sequencing the 1918 Spanish Flu and What do we know About the Novel Coronavirus? - Episode 20
    What can we learn from previous pandemics to apply to the current situation?
    What do we actually know to be true about the novel coronavirus?
    Jeffrey Taubenberger, MD, PhD, a physician-scientist and investigator at the National Institutes of Health, joins us to discuss his landmark work in sequencing the 1918 Spanish flu virus and to provide insights into the current novel coronavirus global pandemic.
    32 min
  • Bruno Larvol, Founder and CEO of Larvol - Preview 1
    Since the human genome has been sequenced, it has become clear that the technology to sequence has far outstripped our capabilities to accurately classify and interpret genetic variants.
    It turns out that genetic variants are much more common than we ever suspected and many - in some cases most - variants are of uncertain significance.
    But is the attempt to accurately classify Variants of Uncertain Significance (VUS) a losing strategy?
    2 min
  • Bruno Larvol, Founder and CEO of the Healthcare Data Company, Larvol - Episode 19
    We have seen tremendous advances in sequencing technology. And the cost to sequence is going to zero, according to Moore's Law. More and more genes and gene sets are being correlated with clinical outcome and response to therapy.
    Is bioinformatics intelligence the missing link to realizing the promise of precision medicine?
    Will a company emerge as the Google or Amazon of cancer informatics?
    Our guest is Bruno Larvol, of the eponymous healthcare data company, Larvol.
    35 min
  • DANE DICKSON, MD, FOUNDER AND CEO OF TAPROOT HEALTH -Preview 1
    There’s no question that we are awash in promising new technologies with the potential to advance precision medicine.
    But is the existing infrastructure adequate to bring innovation into patient care?
    It's generally recognized that the highest levels of evidence are generated via the prospective randomized trial. These trials, however, are extremely costly and time-consuming and generate only a limited number of conclusions from a small subset of patients which may not be truly reflective of the real-world patient experience.
    Will we be able to evolve and find new ways to generate high levels of evidence to move precision medicine forward?
    2 min
  • DAne Dickson, MD, founder and CEO of Taproot Health - Episode 18
    There’s no question that we are awash in promising new technologies with the potential to advance precision medicine.
    But is the existing infrastructure adequate to bring innovation into patient care?
    It's generally recognized that the highest levels of evidence are generated via the prospective randomized trial. These trials, however, are extremely costly and time-consuming and generate only limited conclusions from a small subset of patients which may not be truly reflective of the real-world patient experience.
    Will we be able to evolve and find new ways to generate high levels of evidence to move precision medicine forward?
    Dane Dixon, MD, of Taproot Health joins us in one of our most important episodes to date.
    36 min
  • TRACY GEORGE, MD - EXECUTIVE DIRECTOR OF CLINICAL TRIALS AND PHARMADX AT ARUP LABORATORIES - PREVIEW 4
    The diagnostics #industry is very fragmented, in terms of testing laboratories, test developers, and testing methodologies used.
    Companion diagnostics testing for targeted therapies is still done by a variety of methodologies, including immunohistochemistry, FISH, RT-PCR, RNA expression analysis as well as next-generation sequencing, and others.
    The advent of next-generation #sequencing, as many predicted, has not - as of yet - led to a more unified approach to testing. Why is this?
    2 min

About Personalized Diagnostics

From the publisher's feed

Welcome to the Personalized Diagnostics Podcast.